Abstract
Introduction Earlier diagnosis and better treatment have increased the survival rates of cancer patients. This warrants research on return to work of cancer survivors. What is the return to work rate following early-stage breast cancer? What is the effect of the type of treatment and cancer-related symptoms on return to work? Methods Our occupational health department registers sickness absence of about 50,000 employees. In the period 2001–2005 we counted 154 cases of newly diagnosed breast cancer of which 72 were eligible for analysis. In these women, return to work was followed for 24 months after diagnosis and linked to the type of treatment and cancer-related symptoms. Results The mean duration of absence with early-stage breast cancer was 11.4 ± 5.5 months; 35% of patients were absent longer than one year and 4 patients did not return to work within two years after diagnosis. The duration of absence depended on the type of treatment and was significantly longer in patients who underwent chemotherapy (hazard rate [HR] = 0.31; 95% confidence interval [CI] = 0.12–0.81) or multimodal treatment (HR = 0.24; 95% CI = 0.10–0.54). Women started working about 4 months after the end of therapy irrespective of the type of treatment. At that moment, reaching above shoulder level was impaired in 11 patients (15%) which significantly delayed partial return to work (HR = 0.48; 95% CI = 0.23–0.98) but not full return to work (HR = 0.63; 95% CI = 0.31–1.26). Fatigue was reported by 9 patients (13%) and neither postponed partial return to work nor full return to work. Conclusions The time taken to return to work after early-stage breast cancer was principally determined by the type of treatment.
Similar content being viewed by others
References
Bradley CJ, Bednarek HL, Neumark D. Breast cancer and women’s labor supply. Health Serv Res. 2002;37:1309–28.
Bloom JR, Stewart SL, Chang S, Banks PJ. Then and now: quality of life of young breast cancer survivors. Psychooncology. 2004;13:147–60.
Maunsell E, Drolet M, Brisson J, Brisson C, Masse B, Deschenes L. Work situation after breast cancer: results from a population based study. J Natl Cancer Inst. 2004;96:1813–22.
Van der Wouden J, Greaves-Otte J, Greaves J, Kruyt P, Van Leeuwen O, Van der Does E. Occupational reintegration of long-term cancer survivors. J Occup Med. 1992;34:1084–9.
Kagawa-Singer M. Redefining health: living with cancer. Soc Sci Med. 1993;37:295–304.
Farley Short P, Vasey J, Tunceli K. Employment pathways in a large cohort of adult cancer survivors. Cancer. 2005;103:1292–301.
Bradley C, Oberst K, Schenk M. Absenteeism from work: The experience of employed breast and prostate cancer patients in the months following diagnosis. Psychooncology. 2006;15:739–47.
Spelten ER, Sprangers MAG, Verbeek JHAM. Factors reported to influence return to work of cancer survivors: a literature review. Pyschooncology. 2002;11:124–31.
Maunsell E, Brisson C, Dubois L, Lauzier S, Fraser A. Work problems after breast cancer: an exploratory qualitative study. Psychooncology. 1999;8:467–73.
Amir Z, Moran T, Walsh L, Iddenden R, Luker K. Return to paid work after cancer: A British experience. J Cancer Surviv. 2007;1:129–36.
Nachreiner NM, Dagher RK, McGovern PM, Baker BA, Alexander BH. Gerberich SG Successful return to work for cancer survivors. AAOHN J. 2007;55:290–5.
Pryce J, Munir F, Haslam C. Cancer survivorship and work: symptoms, supervisor response, co-worker disclosure and work adjustment. J Occup Rehabil. 2007;17:83–92.
Janz NK, Mujahid M, Chung LK, Lantz PM, Hawley ST, Morrow M, et al. Symptom experience and quality of life of women following breast cancer treatment. J Womens Health. 2007;16:1348–61.
Sakorafas GH, Peros G. Cataliotti L Sequelae following axillary lymph node dissection for breast cancer. Expert Rev Anticancer Ther. 2006;6:1629–38.
Sakorafas GH, Peros G, Cataliotti L, Vlastos G. Lymfedema following axillary lymph node dissection for breast cancer. Surg Oncol. 2006;15:153–65.
Bower JE, Ganz PA, Desmond KA, Rowland JH, Meyerowitz BE, Berlin TR. Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. Clin Oncol. 2000;18:743–53.
Arndt V, Stegmaier C, Ziegler H, Brenner H. A population-based study of the impact of specific symptoms on the quality of life in women with breast cancer 1 year after diagnosis. Cancer. 2006;107:2496–503.
Meeske K, Smith AW, Alfano CM, McGregor BA, McTiernan A, Baumgartner KB, et al. Fatigue in breast cancer survivors two to five years post diagnosis: a HEAL Study report. Qual Life Res. 2007;16:947–60.
Spelten ER, Verbeek JAHM, Uitterhoeve ALJ, Ansink AC, van der Lelie J, de Rijke TM, et al. Cancer, fatigue and the return of patients to work–a prospective cohort study. Eur J Cancer. 2003;39:1562–7.
Drolet M, Maunsell E, Mondor M, Brisson C, Brisson J, Masse B, et al. Work absence after breast cancer diagnosis: a population-based study. CMAJ. 2005;173:765–71.
Drolet M, Maunsell E, Brisson J, Brisson C, Mâsse B, Dechênes L. Not working 3 years after breast cancer: predictors in a population-based study. J Clin Oncol. 2005;23:8305–12.
De Jong N, Courtens AM, Abu-Saad HH, Schouten HC. Fatigue in patients with breast cancer receiving adjuvant chemotherapy: a review of literature. Cancer Nurs. 2002;25:283–97.
De Jong N, Candel MJ, Schouten HC, Abu-Saad HH, Courtens AM. Prevalence and cause of fatigue in breast cancer patients receiving adjuvant chemotherapy. Ann Oncol. 2004;15:896–905.
Servaes P, Gielissen MF, Verhagen S, Bleijenberg G. The course of severe fatigue in disease-free breast cancer patients: a longitudinal study. Psychooncology. 2007;16:787–95.
Hayes S, Battistutta D, Newman B. Objective and subjective upper body function six months following diagnosis of breast cancer. Breast Cancer Rest Treat. 2005;94:1–10.
Hayes S, Battistutta D, Parker AW, Hirst C, Newman B. Assessing task “burden” of daily activities requiring upper body function among women following breast cancer treatment. Support Care Cancer. 2005;13:255–65.
Rietman JS, Geertzen JH, Hoekstra HJ, Baas P, Dolsma WV, de Vries J, et al. Long term treatment related upper limb morbidity and quality of life after sentinel lymph node biopsy for stage I or II breast cancer. Eur J Surg Oncol. 2006;32:148–52.
Rietman JS, Dijkstra PU, Debreczeni R, Geertzen JH, Robinson DP, de Vries J. Impairments, disabilities and health related quality of life after treatment for breast cancer: a follow-up study 2.7 years after surgery. Disabil Rehabil. 2004;26:78–84.
Dutch Study Group for the Treatment of Breast Cancer. Treatment of breast cancer treatment, Alphen aan den Rijn: Van Zuiden Communications B.V.; 2005 [in Dutch].
Armer JM, Radina ME, Porock D, Culbertson MD. Predicting breast-cancer related lymphedema using self-reported symptoms. Nurs Res. 2003;52:370–9.
Verbeek J, Spelten E, Kammeijer M, Sprangers M. Return to work of cancer survivors: a prospective cohort study into the quality of rehabilitation by occupational physicians. Occup Environ Med. 2003;60:352–7.
Nieuwenhuijsen K, Bos-Ransdorp B, Uitterhoeve LL, Sprangers MA, Verbeek JH. Enhanced provider communication and patient education regarding return to work in cancer survivors following curative treatment: a pilot study. J Occup Rehabil. 2006;16:647–57.
Acknowledgements
The authors wish to thank Prof. Dr. H. J. Hoekstra, of the department of Surgical Oncology of the University Medical Center Groningen, University of Groningen (The Netherlands) for his comments and information about the topical treatment of breast cancer.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Balak, F., Roelen, C.A.M., Koopmans, P.C. et al. Return to Work After Early-stage Breast Cancer: A Cohort Study into the Effects of Treatment and Cancer-related Symptoms. J Occup Rehabil 18, 267–272 (2008). https://doi.org/10.1007/s10926-008-9146-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10926-008-9146-z